US 12,318,420 B2
Herbal formulations of carnivorous plants and methods for treating inflammation
Brandie Gowey, Flagstaff, AZ (US)
Assigned to GOWEY RESEARCH GROUP, PLLC, Flagstaff, AZ (US)
Filed by GOWEY RESEARCH GROUP PLLC, Flagstaff, AZ (US)
Filed on Aug. 25, 2020, as Appl. No. 17/002,461.
Application 17/002,461 is a continuation in part of application No. 16/153,035, filed on Oct. 5, 2018, granted, now 11,344,505.
Application 16/153,035 is a continuation in part of application No. 15/420,374, filed on Jan. 31, 2017, abandoned.
Application 15/420,374 is a continuation in part of application No. 14/990,107, filed on Jan. 7, 2016, granted, now 10,758,578.
Application 17/002,461 is a continuation in part of application No. 14/990,107, filed on Jan. 7, 2016, granted, now 10,758,578.
Application 14/990,107 is a continuation in part of application No. 14/306,581, filed on Jun. 17, 2014, abandoned.
Application 14/990,107 is a continuation in part of application No. 14/305,933, filed on Jun. 16, 2014, abandoned.
Application 14/990,107 is a continuation in part of application No. 13/309,144, filed on Dec. 1, 2011, abandoned.
Claims priority of provisional application 61/835,741, filed on Jun. 17, 2013.
Claims priority of provisional application 61/835,749, filed on Jun. 17, 2013.
Claims priority of provisional application 61/448,824, filed on Mar. 3, 2011.
Claims priority of provisional application 61/418,692, filed on Dec. 1, 2010.
Prior Publication US 2020/0384051 A1, Dec. 10, 2020
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 36/45 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 31/05 (2006.01); A61K 31/352 (2006.01); A61K 36/73 (2006.01); A61K 47/02 (2006.01); A61K 47/12 (2006.01); A61K 47/18 (2017.01); A61K 47/55 (2017.01)
CPC A61K 36/45 (2013.01) [A61K 9/0014 (2013.01); A61K 9/0019 (2013.01); A61K 9/06 (2013.01); A61K 31/05 (2013.01); A61K 31/352 (2013.01); A61K 36/73 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61K 47/183 (2013.01); A61K 47/551 (2017.08)] 7 Claims
 
1. An anti-inflammatory injectable solution comprising a composition for treating inflammation, said composition comprising:
a. an herbal preparation of a carnivorous plant, wherein the herbal preparation is at a range of about 0.1% to 99% volume of the composition, wherein the herbal preparation of the carnivorous plant is prepared from Sarracenia flava, Sarracenia purpurea, or mixed hybrids thereof; and
b. about 0.001% to 25% w/vol of glutathione;
wherein the herbal preparation of the carnivorous plant is effective for facilitating transmission of glutathione to fibroblast growth factors.